Holdings
Kynam Capital Management, LP
As of Sep 30, 2026, Kynam Capital Management, LP reported 30 positions worth US$1.68B. Largest: Legend Biotech Corp., Celldex Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Legend Biotech Corp. | 9.15M | US$182M | new | Sep 30, 2026 |
| Celldex Therapeutics, Inc. | 5.07M | US$164M | −257K | Sep 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 8.15M | US$153M | +100K | Sep 30, 2026 |
| Vaxcyte, Inc. | 2.61M | US$148M | −314K | Sep 30, 2026 |
| Viridian Therapeutics, Inc. | 6.15M | US$127M | −306K | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 3.79M | US$121M | +125K | Sep 30, 2026 |
| Travere Therapeutics, Inc. | 2M | US$118M | no change | Sep 30, 2026 |
| Vera Therapeutics, Inc. | 3M | US$96.9M | +110K | Sep 30, 2026 |
| Beam Therapeutics Inc. | 3.93M | US$96.2M | +1.09M | Sep 30, 2026 |
| CytomX Therapeutics, Inc. | 21.1M | US$57.5M | −562K | Sep 30, 2026 |